Table: RaQualia Pharma -2017 group forecast
Apr 14 (Reuters) -
RaQualia Pharma Inc
CONSOLIDATED EARNINGS ESTIMATES
(in billions of yen unless specified)
Full Year to Full Year to
Dec 31, 2017 Dec 31, 2017
LATEST PREVIOUS
FORECAST FORECAST
Sales 1.18
Operating loss 791 mln
Recurring loss 799 mln
Net loss 800 mln
EPS loss 41.58 yen
NOTE - RaQualia Pharma Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4579.T
((Tokyo Headline News Desk +813 6441 1812))